Exscientia Holdings Limited (EXAI) Social Stream
EXSCIENTIA PLC (EXAI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EXAI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 2 | $27 | $25 | $26 | $6.1 | 326.23% |
| 2022-01-07 | 2 | $25 | $25 | $25 | $6.1 | 309.84% |
| 2022-01-31 | 2 | $25 | $20 | $22.5 | $6.1 | 268.85% |
| 2022-04-11 | 2 | $25 | $21 | $23 | $6.1 | 277.05% |
| 2022-04-18 | 2 | $21 | $20 | $20.5 | $6.1 | 236.07% |
| 2022-05-24 | 3 | $21 | $20 | $20.333 | $6.1 | 233.33% |
| 2022-08-13 | 3 | $20 | $20 | $20 | $6.1 | 227.87% |
| 2022-08-23 | 3 | $20 | $16 | $18.666 | $6.1 | 206% |
| 2022-08-24 | 3 | $20 | $16 | $18 | $6.1 | 195.08% |
| 2022-10-17 | 3 | $20 | $15 | $17 | $6.1 | 178.69% |
| 2023-02-13 | 4 | $20 | $12 | $15.75 | $6.1 | 158.2% |
| 2023-04-24 | 4 | $20 | $12 | $15.5 | $6.1 | 154.1% |
| 2023-06-06 | 3 | $16 | $12 | $14 | $6.1 | 129.51% |
| 2023-07-20 | 4 | $16 | $12 | $14 | $6.1 | 129.51% |
| 2023-08-29 | 4 | $16 | $12 | $13.75 | $6.1 | 125.41% |
| 2023-10-03 | 4 | $14 | $11 | $12.5 | $6.1 | 104.92% |
| 2023-10-10 | 4 | $13 | $7 | $10.75 | $6.1 | 76.23% |
| 2023-11-10 | 4 | $13 | $7 | $10.25 | $6.1 | 68.03% |
The Trend in the Analyst Price Target
EXAI's average price target has moved down $15.75 over the prior 25 months.
Over the past 41 weeks, EXAI's average upside potential has been 110.56%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 4 | 20 | 12 | 15.75 | 6.71 | 134.72% |
| 2023-02-08 | 4 | 20 | 12 | 15.75 | 10.93 | 44.1% |
| 2023-04-24 | 4 | 20 | 12 | 15.50 | 5.13 | 202.14% |
| 2023-05-25 | 3 | 16 | 12 | 14.00 | 7.87 | 77.89% |
| 2023-08-11 | 4 | 16 | 12 | 13.75 | 6.66 | 106.46% |
EXAI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 52 weeks, EXAI's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EXSCIENTIA PLC's number of analysts covering the stock is higher than 176.01% of all US stocks.
- EXSCIENTIA PLC's variance in analysts' estimates is lower than -193.9% of Pharmaceutical Products stocks.
- In terms of how EXSCIENTIA PLC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 1657.61% of that group.
- In the context of stocks in the mid market cap category, EXSCIENTIA PLC's average analyst price target is greater than 485.09% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to EXSCIENTIA PLC are SNDL, ACB, and CRON.
View All Top Stocks by Price Target
What is the outlook for EXAI? Use POWR Ratings for clearer insight into price direction.